Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 458 of the 458 references it cites were found in a registry or an index.

Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities

Open access
Yan, Lu, Guo, Min-Song, Zhang, Yue, Yu, Lu, Wu, Jian-Ming, Tang, Yong, Ai, Wei, Zhu, Feng-Dan, Law, Betty Yuen-Kwan, Chen, Qi, Yu, Chong-Lin, Wong, Vincent Kam-Wai, Li, Hua, Li, Mao, Zhou, Xiao-Gang, Qin, Da-Lian, Wu, An-Guo · 2022 · Oxidative Medicine and Cellular Longevity

Abstract

Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), are characterized by the progressive degeneration of neurons. Although the etiology and pathogenesis of neurodegenerative diseases have been studied intensively, the mechanism is still in its infancy. In general, most neurodegenerative diseases share common molecular mechanisms, and multiple risks interact and promote the pathologic process of neurogenerative diseases. At present, most of the approved drugs only alleviate the clinical symptoms but fail to cure neurodegenerative diseases. Numerous studies indicate that dietary plant polyphenols are safe and exhibit potent neuroprotective effects in various neurodegenerative diseases. However, low bioavailability is the biggest obstacle for polyphenol that largely limits its adoption from evidence into clinical practice. In this review, we summarized the widely recognized mechanisms associated with neurodegenerative diseases, such as misfolded proteins, mitochondrial dysfunction, oxidative damage, and neuroinflammatory responses. In addition, we summarized the research advances about the neuroprotective effect of the most widely reported dietary plant polyphenols. Moreover, we discussed the current clinical study and application of polyphenols and the factors that result in low bioavailability, such as poor stability and low permeability across the blood‐brain barrier (BBB). In the future, the improvement of absorption and stability, modification of structure and formulation, and the combination therapy will provide more opportunities from the laboratory into the clinic for polyphenols. Lastly, we hope that the present review will encourage further researches on natural dietary polyphenols in the treatment of neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2022/5288698

Cites

458 of 458 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The role of misfolded proteins in neurodegenerative diseases. The misfolded proteins, including Aβ, Tau, α-synuclein, and mHtt, induce the overactivation of microglia and neuronal death. The overactivated microglia release the amount of proinflammatory cytokines, including IL-6, IL-1β, IL-18, and TNF-α, and then induce neuroinflammation. Meanwhile, the overactivation of microglia aggravates the aggregation of misfolded proteins. Neuronal death was induced by misfolded proteins through multiple mechanisms, including oxidative stress, mitochondrial dysfunction, excitotoxicity, apoptosis, DNA damage, and synapse degeneration. Both neuroinflammation and neuronal death accelerate the progress of neurodegenerative diseases. However, both ALP and UPS acting as two major degradation pathways not only clear the misfolded proteins but also inhibit neuroinflammation and neuronal death in the early stage of neurodegenerative diseases. However, the overaccumulation of misfolded proteins and degenerated brain impair the normal function of ALP and UPS.
Figure 1 The role of misfolded proteins in neurodegenerative diseases. The misfolded proteins, including Aβ, Tau, α-synuclein, and mHtt, induce the overactivation of microglia and neuronal death. The overactivated microglia release the amount of proinflammatory cytokines, including IL-6, IL-1β, IL-18, and TNF-α, and then induce neuroinflammation. Meanwhile, the overactivation of microglia aggravates the aggregation of misfolded proteins. Neuronal death was induced by misfolded proteins through multiple mechanisms, including oxidative stress, mitochondrial dysfunction, excitotoxicity, apoptosis, DNA damage, and synapse degeneration. Both neuroinflammation and neuronal death accelerate the progress of neurodegenerative diseases. However, both ALP and UPS acting as two major degradation pathways not only clear the misfolded proteins but also inhibit neuroinflammation and neuronal death in the early stage of neurodegenerative diseases. However, the overaccumulation of misfolded proteins and degenerated brain impair the normal function of ALP and UPS.CC BY · PubMed Central
Figure 2 The regulation of the Keap1-Nrf2 pathway under the stimulation of ROS and electrophiles or the treatment of phenolic antioxidants in neurodegenerative diseases. Under basic conditions, Keap1, functioning as a substrate adaptor protein for Cullin3-based Cullin-RING E3 ubiquitin ligase complex around the Cullin3 (Cul3) scaffold protein, mediates the ubiquitination and proteasomal degradation of Nrf2. Under Nrf2 activation, the generated ROS or electrophiles alter the interaction between Nrf2 and its repressors under oxidative stress, resulting in the accumulation of Nrf2 in the cytoplasm and the translocation of Nrf2 into the nucleus, while the phenolic antioxidants (exogenous activator) enhance the effect of the endogenous activator on the Nrf2 pathway, thereby accelerating the dissociation of Nrf2 from Keap1 and leading to more Nrf2 translocation into the nucleus under the conditions of oxidative stress. Through the binding with Maf and ARE, Nrf2 regulates the expression of its downstream target genes, including heme oxygenase-1 (HO-1), NADPH Quinone Dehydrogenase 1 (NQO1), glutathione S-transferase (GST), glutathione peroxidase (GSH-Px), Glutamate-Cysteine Ligase Catalytic Subunit (GCLC), and superoxide dismutase (SOD). Alternatively, Nrf2 is phosphorylated by GSK-3β; then, β-transducin repeat-containing protein (β-TrCP) mediates its interaction with a Cul1 ubiquitin ligase complex to promote the proteasomal degradation of Nrf2, thereby inhibiting the expression of cytoprotective genes. The upregulation of cytoprotective genes prevents the generation of ROS levels, as well as oxidative damage, neuroinflammation, mitochondrial dysfunction, neuronal cell death, and protein aggregation.
Figure 2 The regulation of the Keap1-Nrf2 pathway under the stimulation of ROS and electrophiles or the treatment of phenolic antioxidants in neurodegenerative diseases. Under basic conditions, Keap1, functioning as a substrate adaptor protein for Cullin3-based Cullin-RING E3 ubiquitin ligase complex around the Cullin3 (Cul3) scaffold protein, mediates the ubiquitination and proteasomal degradation of Nrf2. Under Nrf2 activation, the generated ROS or electrophiles alter the interaction between Nrf2 and its repressors under oxidative stress, resulting in the accumulation of Nrf2 in the cytoplasm and the translocation of Nrf2 into the nucleus, while the phenolic antioxidants (exogenous activator) enhance the effect of the endogenous activator on the Nrf2 pathway, thereby accelerating the dissociation of Nrf2 from Keap1 and leading to more Nrf2 translocation into the nucleus under the conditions of oxidative stress. Through the binding with Maf and ARE, Nrf2 regulates the expression of its downstream target genes, including heme oxygenase-1 (HO-1), NADPH Quinone Dehydrogenase 1 (NQO1), glutathione S-transferase (GST), glutathione peroxidase (GSH-Px), Glutamate-Cysteine Ligase Catalytic Subunit (GCLC), and superoxide dismutase (SOD). Alternatively, Nrf2 is phosphorylated by GSK-3β; then, β-transducin repeat-containing protein (β-TrCP) mediates its interaction with a Cul1 ubiquitin ligase complex to promote the proteasomal degradation of Nrf2, thereby inhibiting the expression of cytoprotective genes. The upregulation of cytoprotective genes prevents the generation of ROS levels, as well as oxidative damage, neuroinflammation, mitochondrial dysfunction, neuronal cell death, and protein aggregation.CC BY · PubMed Central
Figure 3 The mitochondrial dysfunction and DNA damage in neurodegenerative diseases. The increasingly accumulated misfolded proteins (Aβ, Tau, α-synuclein, mHtt, etc.) damage the normal function of mitochondria, thus resulting in the opening of the mitochondrial permeability transition pore (MPTP). The damaged mitochondria exhibit reduced ATP levels, increased ROS generation, decreased MMP, and increased release of cytochrome c (CytoC) into the cytosol, which promotes the formation of the apoptosome and subsequent proteolytical cleavage of procaspase-3 and procaspase-7, into the activated forms. Meanwhile, the loss of MMP results in the release of apoptosis-inducing factor (AIF) that is on the cytosolic side of the outer membrane of the mitochondria into the cytosol. The activation of caspases and accumulation of AIF ultimately induce neuronal cell apoptosis. In addition, the generation of large amounts of ROS induces the production and accumulation of lipid peroxidation, which indicates that neurons undergo ferroptosis. It is worth noting that the damaged mitochondria in turn further exacerbate the aggregation of misfolded proteins. In addition, the increasingly accumulated misfolded proteins induce DNA damage in the nucleus. The damaged DNA then activates PARP-1, which catalyzes PAR formation. The free PAR translocates from the nucleus to the cytosol and mitochondria where it binds AIF, inducing AIF release from the mitochondria. Then, AIF binds the parthanatos AIF-associated nuclease (PAAN) and translocates to the nucleus and causes the generation of DNA fragmentation, which induces neuronal cell death via parthanatos.
Figure 3 The mitochondrial dysfunction and DNA damage in neurodegenerative diseases. The increasingly accumulated misfolded proteins (Aβ, Tau, α-synuclein, mHtt, etc.) damage the normal function of mitochondria, thus resulting in the opening of the mitochondrial permeability transition pore (MPTP). The damaged mitochondria exhibit reduced ATP levels, increased ROS generation, decreased MMP, and increased release of cytochrome c (CytoC) into the cytosol, which promotes the formation of the apoptosome and subsequent proteolytical cleavage of procaspase-3 and procaspase-7, into the activated forms. Meanwhile, the loss of MMP results in the release of apoptosis-inducing factor (AIF) that is on the cytosolic side of the outer membrane of the mitochondria into the cytosol. The activation of caspases and accumulation of AIF ultimately induce neuronal cell apoptosis. In addition, the generation of large amounts of ROS induces the production and accumulation of lipid peroxidation, which indicates that neurons undergo ferroptosis. It is worth noting that the damaged mitochondria in turn further exacerbate the aggregation of misfolded proteins. In addition, the increasingly accumulated misfolded proteins induce DNA damage in the nucleus. The damaged DNA then activates PARP-1, which catalyzes PAR formation. The free PAR translocates from the nucleus to the cytosol and mitochondria where it binds AIF, inducing AIF release from the mitochondria. Then, AIF binds the parthanatos AIF-associated nuclease (PAAN) and translocates to the nucleus and causes the generation of DNA fragmentation, which induces neuronal cell death via parthanatos.CC BY · PubMed Central
Figure 4 The role of excitotoxicity in neurodegenerative diseases. In presynaptic neurons, glutamate (Glu) is generated through the conversion of Glutamine (Gln) with the action of glutaminase. Glu is stored in the vesicles by vesicular glutamate transporters (vGLUTs). Then, Glu is released from the vesicles and out of presynaptic neurons owing to the depolarization of the presynaptic membrane. Then, Glu binds with the ionotropic glutamate receptors (iGluRs), such as N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in the postsynaptic membrane, and generates an action potential. The binding of Glu with AMPA results in Na+ influx and consequent membrane depolarization and opening of voltage-dependent Ca2+ channels (VDCC). Meanwhile, the binding of Glu with NMDA receptors (NMDARs) leads to the opening of the NMDA receptor channel under depolarizing conditions, resulting in large amounts of Ca2+ influx. Finally, the increased levels of cytoplasmic Ca2+ induce the uptake of Ca2+ uptake into the mitochondria, which then induces the production of reactive oxygen species (ROS) and decreases ATP levels, ultimately resulting in neuronal cell death. The excitatory amino acid transporter 3 (EAAT3) is a transporter of Glu present at the postsynaptic neuronal element. In addition, the excessively released Glu in the synaptic cleft is transported into astrocytes through the EAAT1 and EAAT2 transporters. In astrocytes, Glu is recycled and converted to Gln which is transported to neurons and converted into Glu again.
Figure 4 The role of excitotoxicity in neurodegenerative diseases. In presynaptic neurons, glutamate (Glu) is generated through the conversion of Glutamine (Gln) with the action of glutaminase. Glu is stored in the vesicles by vesicular glutamate transporters (vGLUTs). Then, Glu is released from the vesicles and out of presynaptic neurons owing to the depolarization of the presynaptic membrane. Then, Glu binds with the ionotropic glutamate receptors (iGluRs), such as N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in the postsynaptic membrane, and generates an action potential. The binding of Glu with AMPA results in Na+ influx and consequent membrane depolarization and opening of voltage-dependent Ca2+ channels (VDCC). Meanwhile, the binding of Glu with NMDA receptors (NMDARs) leads to the opening of the NMDA receptor channel under depolarizing conditions, resulting in large amounts of Ca2+ influx. Finally, the increased levels of cytoplasmic Ca2+ induce the uptake of Ca2+ uptake into the mitochondria, which then induces the production of reactive oxygen species (ROS) and decreases ATP levels, ultimately resulting in neuronal cell death. The excitatory amino acid transporter 3 (EAAT3) is a transporter of Glu present at the postsynaptic neuronal element. In addition, the excessively released Glu in the synaptic cleft is transported into astrocytes through the EAAT1 and EAAT2 transporters. In astrocytes, Glu is recycled and converted to Gln which is transported to neurons and converted into Glu again.CC BY · PubMed Central
Figure 5 The key role of BDNF in the regulation of neuronal cell death and survival. Pre-proBDNF undergoes processing and cleavage to generate proBDNF, which is further processed to mature BDNF (mBDNF). Both proBDNF and mBDNF are stored in the proteases. ProBDNF undergoes low levels of constitutive release, while mBDNF associated with synaptic plasticity is released in an activity-dependent manner. Then, the signaling cascades are activated by the interaction of BDNF isoforms with the cell receptors located on the membrane of postsynaptic neurons, including the p75 neurotrophin receptor (p75NTR) and tropomyosin receptor kinase B (TrkB) receptor. Among them, proBDNF has a greater affinity with the p75NTR and forms the proBDNF/p75/sortilin complex, which leads to the activation of c-Jun N-terminal kinase (JNK), Ras homolog gene family member (RhoA), and nuclear factor kappa B (NF-κB) signaling pathways, subsequently induces apoptosis, neuronal growth and development, and neuronal survival, respectively. In addition, mBDNF binds with TrbB and forms the mBDNF/TrkB receptor complex, which activates the following signaling pathways, including mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), and phospholipase C-γ (PLC-γ). Then, the transcription factor cAMP response element-binding protein (CREB) and transcription of genes are activated. Gene modulation induces neuronal differentiation, survival, and synaptic plasticity.
Figure 5 The key role of BDNF in the regulation of neuronal cell death and survival. Pre-proBDNF undergoes processing and cleavage to generate proBDNF, which is further processed to mature BDNF (mBDNF). Both proBDNF and mBDNF are stored in the proteases. ProBDNF undergoes low levels of constitutive release, while mBDNF associated with synaptic plasticity is released in an activity-dependent manner. Then, the signaling cascades are activated by the interaction of BDNF isoforms with the cell receptors located on the membrane of postsynaptic neurons, including the p75 neurotrophin receptor (p75NTR) and tropomyosin receptor kinase B (TrkB) receptor. Among them, proBDNF has a greater affinity with the p75NTR and forms the proBDNF/p75/sortilin complex, which leads to the activation of c-Jun N-terminal kinase (JNK), Ras homolog gene family member (RhoA), and nuclear factor kappa B (NF-κB) signaling pathways, subsequently induces apoptosis, neuronal growth and development, and neuronal survival, respectively. In addition, mBDNF binds with TrbB and forms the mBDNF/TrkB receptor complex, which activates the following signaling pathways, including mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), and phospholipase C-γ (PLC-γ). Then, the transcription factor cAMP response element-binding protein (CREB) and transcription of genes are activated. Gene modulation induces neuronal differentiation, survival, and synaptic plasticity.CC BY · PubMed Central
Figure 6 The classification of polyphenols. Polyphenols mainly include flavonoids, phenolic acids, phenolic alcohols, stilbenes, lignans, curcuminoids, and coumarins. Flavonoids are subclassified into flavanols, flavanones, anthocyanins, flavonols, flavones, isoflavones, etc. Phenolic acids are divided into hydroxybenzoic acids and hydroxycinnamic acids. The representative image of plants enriching the corresponding polyphenols.
Figure 6 The classification of polyphenols. Polyphenols mainly include flavonoids, phenolic acids, phenolic alcohols, stilbenes, lignans, curcuminoids, and coumarins. Flavonoids are subclassified into flavanols, flavanones, anthocyanins, flavonols, flavones, isoflavones, etc. Phenolic acids are divided into hydroxybenzoic acids and hydroxycinnamic acids. The representative image of plants enriching the corresponding polyphenols.CC BY · PubMed Central
Figure 7 The potential treatment of natural polyphenols in neurodegenerative diseases. The natural plants especially the dietary food, such as grape, green tee, and litchi, enrich polyphenols, together with the widely reported polyphenols, such as resveratrol, curcumin, and quercetin, exhibit potent neuroprotective effects mainly involving inhibition of neuronal death and glial overactivation. The molecular mechanisms associated with the progress of neurogenerative diseases (AD, PD, HD, ALS, MS, etc.) include DNA damage, mitochondrial dysfunction, oxidative stress, excitotoxicity, biometal dyshomeostasis, neurotrophic impairment, neuroinflammatory responses, and the aggregation of misfolded proteins.
Figure 7 The potential treatment of natural polyphenols in neurodegenerative diseases. The natural plants especially the dietary food, such as grape, green tee, and litchi, enrich polyphenols, together with the widely reported polyphenols, such as resveratrol, curcumin, and quercetin, exhibit potent neuroprotective effects mainly involving inhibition of neuronal death and glial overactivation. The molecular mechanisms associated with the progress of neurogenerative diseases (AD, PD, HD, ALS, MS, etc.) include DNA damage, mitochondrial dysfunction, oxidative stress, excitotoxicity, biometal dyshomeostasis, neurotrophic impairment, neuroinflammatory responses, and the aggregation of misfolded proteins.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 458 references

Research works printed but not linked: 3

  1. Lilienbaum A., 2013, Relationship between the proteasomal system and autophagy, International Journal of Biochemistry and Molecular Biology, 4, 1
  2. 10.5740/jaoacint.19-0133 · doi:10.5740/jaoacint.19-0133 · Paper page
  3. Liang L., 2018, Anti-oxidative stress effects of curcumin on rat models of traumatic brain injury, Chinese Journal of Comparative Medicine, 28, 73

Cited by

See all 97

Metadata

Authors
Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., Yu, C.-L., Wong, V. K.-W., Li, H., Li, M., Zhou, X.-G., Qin, D.-L., & Wu, A.-G.
Affiliations
  • Southwest Medical University (CN)
  • Macau University of Science and Technology (MO)
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2022-01
Volume
2022
Issue
1
Pages
5288698-5288698
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W4212904553
Cited by
97
References
458
Citations by year
2026: 16 · 2025: 25 · 2024: 27 · 2023: 19 · 2022: 10
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Southwest Medical University (2021ZKMS046, 2021ZKZD018, 2021ZKZD015)
  • National Natural Science Foundation of China (81801398, 81903829)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
neurodegenerative diseases, neuroprotection, Alzheimer's disease, Parkinson's disease, Huntington's disease, polyphenol bioavailability, blood-brain barrier, mitochondrial dysfunction, oxidative stress, neuroinflammation, protein misfolding, combination therapy, natural product drug development
MeSH terms
Animals, Antioxidants, Biological Availability, Biological Transport, Blood-Brain Barrier, Disease Models, Animal, Humans, Phytotherapy, Plant Extracts, Treatment Outcome, Oxidative Stress, Neuroprotective Agents, Neurodegenerative Diseases, Polyphenols, Phytochemicals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities. https://app.cochat.ai/papers/10.1155/2022/5288698
The paper
Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., Yu, C.-L., Wong, V. K.-W., Li, H., Li, M., Zhou, X.-G., Qin, D.-L., & Wu, A.-G. (2022). Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2022/5288698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.